QuidelOrtho
QDEL
#3659
Rank
NZ$4.92 B
Marketcap
$73.19
Share price
12.61%
Change (1 day)
-27.38%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

P/S ratio for QuidelOrtho (QDEL)

P/S ratio as of November 2024 (TTM): 1.04

According to QuidelOrtho's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9269. At the end of 2024 the company had a P/S ratio of 0.7849.

P/S ratio history for QuidelOrtho from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.7849-52.22%
20231.64-5.18%
20221.73-47.71%
20213.31-27.16%
20204.55-22.56%
20195.8759.52%
20183.68-30.62%
20175.3145.4%
20163.651.32%
20153.60-33.82%
20145.44-9.29%
20136.0049.63%
20124.0126.43%
20113.17-12.75%
20103.6449.31%
20092.43-26.67%
20083.32-38.44%
20075.3925.21%
20064.318.99%
20053.9589.8%
20042.08-39.52%
20033.44162.06%
20021.31-56.4%
20013.01

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.47 330.82%๐Ÿ‡บ๐Ÿ‡ธ USA
3.38 225.39%๐Ÿ‡บ๐Ÿ‡ธ USA
4.98 380.25%๐Ÿ‡บ๐Ÿ‡ธ USA
1.17 12.74%๐Ÿ‡บ๐Ÿ‡ธ USA
8.85 752.70%๐Ÿ‡บ๐Ÿ‡ธ USA
4.31 314.90%๐Ÿ‡บ๐Ÿ‡ธ USA